辅助子单元KChIP2c和DPP6通过riluzole差异调节Kv4.2通道的抑制
Mayra Delgado-Ramírez1, David O Pacheco-Rojas1, Kathya Villatoro-Gomez1
1Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Av. 25 de Julio 965 Col, Villas San Sebastián, Colima, COL, 28045, Mexico.
European journal of pharmacology
|November 25, 2024
概括
里卢醇是一种可靠的药物.
科学领域:
- 分子和细胞神经科学
- 离子通道药理学 离子通道药理学
背景情况:
- Kv4.2通道对于神经元和心脏的电活动至关重要.
- 辅助子单位,KChIP和DPP,调节Kv4.2通道功能.
- 药理学调节Kv4.2的药物,如瑞卢,特别是与共同表达的子单元,是不太了解.
研究的目的:
- 为了研究KChIP2c和DPP6对riluzole对Kv4.2通道抑制的影响.
- 探索依赖状态的药物结合及其对通道动态的影响.
主要方法:
- 对Kv4.2,Kv4.2/KChIP2c和Kv4.2/DPP6通道的电生理记录.
- 电压分析以评估瑞卢的抑制作用.
- 频道激活,非激活和恢复的动态分析.
主要成果:
- 利卢以电压独立的方式抑制了Kv4.2通道,辅助子单元 (Kv4.2/DPP6>Kv4.2>Kv4.2/KChIP2c) 影响的强度不同.
- 利卢改变了通道门,包括左移动的失活曲线和增强封闭状态的失活,具有依赖子单元的效应.
- 根据共同表达的子单位观察到对无活化动力学,无活化恢复和闭状态无活化率的明显影响.
结论:
- 辅助子单元显著调节利卢在Kv4.2通道上的药理作用.
- 瑞卢在KChIP2c或DPP6.6的存在上表现出差异性的抑制和动力调节.
- 这些发现凸显了辅助子单元在确定离子通道向药物的器官特异性作用方面的重要性.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
251
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
251
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
Voltage-gated Ion Channels
8.0K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.0K
Non-gated Ion Channels
6.7K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.7K
Ligand-gated Ion Channels
12.2K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.2K


